🇺🇸 FDA
Patent

US 10285935

Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology

granted A61KA61K9/0019A61K9/0085

Quick answer

US patent 10285935 (Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology) held by United States Department of Veteran Affairs expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Department of Veteran Affairs
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K9/0019, A61K9/0085